{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:57:31Z","timestamp":1782352651268,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:00:00Z","timestamp":1627257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T00:00:00Z","timestamp":1627257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00417-021-05320-y","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T04:02:55Z","timestamp":1627272175000},"page":"73-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficiency comparison with fovea-sparing internal limiting membrane peeling and complete internal limiting membrane peeling for treating myopic traction maculopathy"],"prefix":"10.1007","volume":"260","author":[{"given":"Wen-Jian","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Ze","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei-Bing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Juan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Xin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6667-0563","authenticated-orcid":false,"given":"Yun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,26]]},"reference":[{"key":"5320_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/opo.12238","volume":"35","author":"PK Verkicharla","year":"2015","unstructured":"Verkicharla PK, Ohno-Matsui K, Saw SM (2015) Current and predicted demographics of high myopia and an update of its associated pathological changes. Ophthalmic Physiol Opt 35:465\u2013475. https:\/\/doi.org\/10.1111\/opo.12238","journal-title":"Ophthalmic Physiol Opt"},{"key":"5320_CR2","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1167\/iovs.12-9919","volume":"53","author":"SJ Chen","year":"2012","unstructured":"Chen SJ, Cheng CY, Li AF, Peng KL, Chou P, Chiou SH, Hsu WM (2012) Prevalence and associated risk factors of myopic maculopathy in elderly Chinese: the Shihpai eye study. Invest Ophthalmol Vis Sci 53:4868\u20134873. https:\/\/doi.org\/10.1167\/iovs.12-9919","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5320_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ophtha.2003.05.011","volume":"111","author":"WM Hsu","year":"2004","unstructured":"Hsu WM, Cheng CY, Liu JH, Tsai SY, Chou P (2004) Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 111:62\u201369. https:\/\/doi.org\/10.1016\/j.ophtha.2003.05.011","journal-title":"Ophthalmology"},{"key":"5320_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1001\/archopht.125.6.767","volume":"125","author":"G Panozzo","year":"2007","unstructured":"Panozzo G, Mercanti A (2007) Vitrectomy for myopic traction maculopathy. Arch Ophthalmol 125:767\u2013772. https:\/\/doi.org\/10.1001\/archopht.125.6.767","journal-title":"Arch Ophthalmol"},{"key":"5320_CR5","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.2147\/opth.s237483","volume":"14","author":"R Frisina","year":"2020","unstructured":"Frisina R, Gius I, Palmieri M, Finzi A, Tozzi L, Parolini B (2020) Myopic traction maculopathy: diagnostic and management strategies. Clin Ophthalmol 14:3699\u20133708. https:\/\/doi.org\/10.2147\/opth.s237483","journal-title":"Clin Ophthalmol"},{"key":"5320_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000360468","volume":"54","author":"M G\u00f3mez-Resa","year":"2014","unstructured":"G\u00f3mez-Resa M, Bur\u00e9s-Jelstrup A, Mateo C (2014) Myopic traction maculopathy. Dev Ophthalmol 54:204\u2013212. https:\/\/doi.org\/10.1159\/000360468","journal-title":"Dev Ophthalmol"},{"key":"5320_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.preteyeres.2018.10.005","volume":"69","author":"J Ruiz-Medrano","year":"2019","unstructured":"Ruiz-Medrano J, Montero JA, Flores-Moreno I, Arias L, Garc\u00eda-Layana A, Ruiz-Moreno JM (2019) Myopic maculopathy: current status and proposal for a new classification and grading system (ATN). Prog Retin Eye Res 69:80\u2013115. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.10.005","journal-title":"Prog Retin Eye Res"},{"key":"5320_CR8","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3928\/23258160-20201005-05","volume":"51","author":"TQ Duan","year":"2020","unstructured":"Duan TQ, Tan W, Yang J, Li FL, Xiong SQ, Wang XG, Xu HZ (2020) Morphological characteristics predict postoperative outcomes after vitrectomy in myopic traction maculopathy patients. Ophthalmic Surg Lasers Imaging Retina 51:574\u2013582. https:\/\/doi.org\/10.3928\/23258160-20201005-05","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"5320_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3341\/kjo.2019.0115","volume":"34","author":"CY Kim","year":"2020","unstructured":"Kim CY, Kim MS, Kim KL, Woo SJ, Park KH (2020) Prognostic factors related with surgical outcome of vitrectomy in myopic traction maculopathy. Korean J Ophthalmol 34:67\u201375. https:\/\/doi.org\/10.3341\/kjo.2019.0115","journal-title":"Korean J Ophthalmol"},{"key":"5320_CR10","doi-asserted-by":"publisher","unstructured":"Wu J, Xu Q, Luan J (2020) Vitrectomy with fovea-sparing ILM peeling versus total ILM peeling for myopic traction maculopathy: a meta-analysis. Eur J Ophthalmol 1120672120970111. https:\/\/doi.org\/10.1177\/1120672120970111","DOI":"10.1177\/1120672120970111"},{"key":"5320_CR11","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/s0161-6420(03)00714-0","volume":"110","author":"H Kobayashi","year":"2003","unstructured":"Kobayashi H, Kishi S (2003) Vitreous surgery for highly myopic eyes with foveal detachment and retinoschisis. Ophthalmology 110:1702\u20131707. https:\/\/doi.org\/10.1016\/s0161-6420(03)00714-0","journal-title":"Ophthalmology"},{"key":"5320_CR12","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1097\/iae.0000000000000149","volume":"34","author":"TC Ho","year":"2014","unstructured":"Ho TC, Yang CM, Huang JS, Yang CH, Yeh PT, Chen TC, Ho A, Chen MS (2014) Long-term outcome of foveolar internal limiting membrane nonpeeling for myopic traction maculopathy. Retina 34:1833\u20131840. https:\/\/doi.org\/10.1097\/iae.0000000000000149","journal-title":"Retina"},{"key":"5320_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10384-019-00696-1","volume":"64","author":"M Iwasaki","year":"2020","unstructured":"Iwasaki M, Miyamoto H, Okushiba U, Imaizumi H (2020) Fovea-sparing internal limiting membrane peeling versus complete internal limiting membrane peeling for myopic traction maculopathy. Jpn J Ophthalmol 64:13\u201321. https:\/\/doi.org\/10.1007\/s10384-019-00696-1","journal-title":"Jpn J Ophthalmol"},{"key":"5320_CR14","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1136\/bjophthalmol-2012-302035","volume":"96","author":"R Tadayoni","year":"2012","unstructured":"Tadayoni R, Svorenova I, Erginay A, Gaudric A, Massin P (2012) Decreased retinal sensitivity after internal limiting membrane peeling for macular hole surgery. Br J Ophthalmol 96:1513\u20131516. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-302035","journal-title":"Br J Ophthalmol"},{"key":"5320_CR15","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1111\/aos.13115","volume":"95","author":"CL Lee","year":"2017","unstructured":"Lee CL, Wu WC, Chen KJ, Chiu LY, Wu KY, Chang YC (2017) Modified internal limiting membrane peeling technique (maculorrhexis) for myopic foveoschisis surgery. Acta Ophthalmol 95:e128\u2013e131. https:\/\/doi.org\/10.1111\/aos.13115","journal-title":"Acta Ophthalmol"},{"key":"5320_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/1120672117750059","volume":"29","author":"MM Elwan","year":"2019","unstructured":"Elwan MM, Abd Elghafar AE, Hagras SM, Abou Samra WA, Saleh SM (2019) Long-term outcome of internal limiting membrane peeling with and without foveal sparing in myopic foveoschisis. Eur J Ophthalmol 29:69\u201374. https:\/\/doi.org\/10.1177\/1120672117750059","journal-title":"Eur J Ophthalmol"},{"key":"5320_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ajo.2012.04.013","volume":"154","author":"N Shimada","year":"2012","unstructured":"Shimada N, Sugamoto Y, Ogawa M, Takase H, Ohno-Matsui K (2012) Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy. Am J Ophthalmol 154:693\u2013701. https:\/\/doi.org\/10.1016\/j.ajo.2012.04.013","journal-title":"Am J Ophthalmol"},{"key":"5320_CR18","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/IAE.0b013e3181c703fc","volume":"30","author":"K Kumagai","year":"2010","unstructured":"Kumagai K, Furukawa M, Ogino N, Larson E (2010) Factors correlated with postoperative visual acuity after vitrectomy and internal limiting membrane peeling for myopic foveoschisis. Retina 30:874\u2013880. https:\/\/doi.org\/10.1097\/IAE.0b013e3181c703fc","journal-title":"Retina"},{"key":"5320_CR19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00417-004-1121-6","volume":"243","author":"L Kodjikian","year":"2005","unstructured":"Kodjikian L, Richter T, Halberstadt M, Beby F, Flueckiger F, Boehnke M, Garweg JG (2005) Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium. Graefes Arch Clin Exp Ophthalmol 243:917\u2013925. https:\/\/doi.org\/10.1007\/s00417-004-1121-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5320_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000138974","volume":"42","author":"A Gandorfer","year":"2008","unstructured":"Gandorfer A, Haritoglou C, Kampik A (2008) Toxicity of indocyanine green in vitreoretinal surgery. Dev Ophthalmol 42:69\u201381. https:\/\/doi.org\/10.1159\/000138974","journal-title":"Dev Ophthalmol"},{"key":"5320_CR21","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/sj.eye.6702220","volume":"20","author":"A Awan","year":"2006","unstructured":"Awan A, Yang YC (2006) Shellfish allergy: a contraindication for fundus fluorescein angiography; misconception or reality. Eye (Lond) 20:1383\u20131384. https:\/\/doi.org\/10.1038\/sj.eye.6702220","journal-title":"Eye (Lond)"},{"key":"5320_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1089\/jop.2011.0221","volume":"28","author":"Z Su","year":"2012","unstructured":"Su Z, Ye P, Teng Y, Zhang L, Shu X (2012) Adverse reaction in patients with drug allergy history after simultaneous intravenous fundus fluorescein angiography and indocyanine green angiography. J Ocul Pharmacol Ther 28:410\u2013413. https:\/\/doi.org\/10.1089\/jop.2011.0221","journal-title":"J Ocul Pharmacol Ther"},{"key":"5320_CR23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.survophthal.2019.02.004","volume":"64","author":"IS Kornblau","year":"2019","unstructured":"Kornblau IS, El-Annan JF (2019) Adverse reactions to fluorescein angiography: a comprehensive review of the literature. Surv Ophthalmol 64:679\u2013693. https:\/\/doi.org\/10.1016\/j.survophthal.2019.02.004","journal-title":"Surv Ophthalmol"},{"key":"5320_CR24","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.oret.2020.05.016","volume":"4","author":"N Shiraki","year":"2020","unstructured":"Shiraki N, Wakabayashi T, Ikuno Y, Matsumura N, Sato S, Sakaguchi H, Nishida K (2020) fovea-sparing versus standard internal limiting membrane peeling for myopic traction maculopathy: a study of 102 consecutive cases. Ophthalmol Retina 4:1170\u20131180. https:\/\/doi.org\/10.1016\/j.oret.2020.05.016","journal-title":"Ophthalmol Retina"},{"key":"5320_CR25","doi-asserted-by":"publisher","first-page":"e14710","DOI":"10.1097\/md.0000000000014710","volume":"98","author":"L Wang","year":"2019","unstructured":"Wang L, Wang Y, Li Y, Yan Z, Li Y, Lu L, Lu T, Wang X, Zhang S, Shang Y (2019) Comparison of effectiveness between complete internal limiting membrane peeling and internal limiting membrane peeling with preservation of the central fovea in combination with 25G vitrectomy for the treatment of high myopic foveoschisis. Medicine 98:e14710. https:\/\/doi.org\/10.1097\/md.0000000000014710","journal-title":"Medicine"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05320-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-021-05320-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05320-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T14:24:38Z","timestamp":1642515878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-021-05320-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,26]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["5320"],"URL":"https:\/\/doi.org\/10.1007\/s00417-021-05320-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,26]]},"assertion":[{"value":"23 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the ethics committee of General Hospital of Xinjiang Military Region. The patients\/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article. The study protocol of this study conforms to the ethical guidelines of the 1975 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}